EndoTheia
Private Company
Total funding raised: $1.8M
Overview
EndoTheia is a privately-held, pre-revenue medical device innovator focused on revolutionizing flexible endoscopic procedures. The company's core technology platform involves intelligently micro-machined smart materials to create ultra-thin, steerable sheaths and manipulators that work alongside existing endoscopes, granting surgeons independent tool control and access to challenging anatomy. Primarily funded through government grants, EndoTheia is advancing a platform that could enable new paradigms in endoscopic surgery and drug delivery. Its leadership combines deep expertise in robotics, engineering, and clinical medicine, positioning it to address significant limitations in current minimally invasive surgical tools.
Technology Platform
Proprietary micromanufacturing of smart materials to create ultra-thin, dexterous, steerable sheath systems for flexible endoscopes. The platform enables independent tool motion, enhanced visualization, and delivery of therapeutics at millimeter scales.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
EndoTheia competes in the advanced endoscopic tooling and emerging surgical robotics space. Competitors include large players like Boston Scientific, Medtronic, and Olympus, which are investing in robotic endoscopy, as well as startups like EndoQuest Robotics and Virtuoso Surgical. EndoTheia's differentiation lies in its extreme miniaturization and focus on augmenting, rather than replacing, current endoscopes.